Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H28ClN5O.ClH |
Molecular Weight | 414.372 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCN1C(=O)N(CCCN2CCN(CC2)C3=CC=CC(Cl)=C3)N=C1CC
InChI
InChIKey=BHKPQZVLIZKSAG-UHFFFAOYSA-N
InChI=1S/C19H28ClN5O.ClH/c1-3-18-21-25(19(26)24(18)4-2)10-6-9-22-11-13-23(14-12-22)17-8-5-7-16(20)15-17;/h5,7-8,15H,3-4,6,9-14H2,1-2H3;1H
Etoperidone is an atypical antidepressant introduced in Europe in 1977. The activity of etoperidone is made mainly by its major metabolite 1-(3'-chlorophenyl)piperazine (mCPP). mCPP binds with different affinity to most of the serotonergic receptors and adrenergic receptors. This metabolite is an agonist of 5-HT2c and an antagonist of 5-HT2a. Part of etoperidone structure contributes to the activity in the α-adrenergic receptors. Etoperidone has been studied for the treatment of depression, tremors in Parkinson, extrapyramidal symptoms and male impotence. It is not certain if it was ever approved and marketed but its current status is withdrawn.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094251 Sources: https://www.drugbank.ca/drugs/DB09194 |
38.0 nM [Kd] | ||
Target ID: CHEMBL2095158 Sources: https://www.drugbank.ca/drugs/DB09194 |
570.0 nM [Kd] | ||
Target ID: CHEMBL217 |
2.3 µM [Kd] | ||
Target ID: CHEMBL214 |
85.0 nM [Kd] | ||
Target ID: CHEMBL2095200 |
36.0 nM [Kd] |
PubMed
Title | Date | PubMed |
---|---|---|
Binding of antidepressants to human brain receptors: focus on newer generation compounds. | 1994 May |
|
Pharmacological profile of antidepressants and related compounds at human monoamine transporters. | 1997 Dec 11 |
|
Thioridazine for dementia. | 2001 |
|
Evaluation of the absorption, excretion and metabolism of [14C] etoperidone in man. | 2001 Nov |
|
In vitro identification of metabolic pathways and cytochrome P450 enzymes involved in the metabolism of etoperidone. | 2002 Nov |
|
A comparative solid-phase extraction study for the simultaneous determination of fluvoxamine, mianserin, doxepin, citalopram, paroxetine, and etoperidone in whole blood by capillary gas-liquid chromatography with nitrogen-phosphorus detection. | 2004 Apr |
|
Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram. | 2008 Aug 19 |
|
Detection of novel reactive metabolites of trazodone: evidence for CYP2D6-mediated bioactivation of m-chlorophenylpiperazine. | 2008 May |
|
5-(4-Chloro-phen-yl)-3-(2,4-dimethyl-thiazol-5-yl)-1,2,4-triazolo[3,4-a]isoquinoline. | 2010 Apr 10 |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C267
Created by
admin on Fri Dec 15 16:12:07 GMT 2023 , Edited by admin on Fri Dec 15 16:12:07 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
AA-31
Created by
admin on Fri Dec 15 16:12:07 GMT 2023 , Edited by admin on Fri Dec 15 16:12:07 GMT 2023
|
PRIMARY | |||
|
CHEMBL1743259
Created by
admin on Fri Dec 15 16:12:07 GMT 2023 , Edited by admin on Fri Dec 15 16:12:07 GMT 2023
|
PRIMARY | |||
|
304398
Created by
admin on Fri Dec 15 16:12:07 GMT 2023 , Edited by admin on Fri Dec 15 16:12:07 GMT 2023
|
PRIMARY | |||
|
C63783
Created by
admin on Fri Dec 15 16:12:07 GMT 2023 , Edited by admin on Fri Dec 15 16:12:07 GMT 2023
|
PRIMARY | |||
|
57775-22-1
Created by
admin on Fri Dec 15 16:12:07 GMT 2023 , Edited by admin on Fri Dec 15 16:12:07 GMT 2023
|
PRIMARY | |||
|
100000183776
Created by
admin on Fri Dec 15 16:12:07 GMT 2023 , Edited by admin on Fri Dec 15 16:12:07 GMT 2023
|
PRIMARY | |||
|
65472
Created by
admin on Fri Dec 15 16:12:07 GMT 2023 , Edited by admin on Fri Dec 15 16:12:07 GMT 2023
|
PRIMARY | |||
|
DBSALT002572
Created by
admin on Fri Dec 15 16:12:07 GMT 2023 , Edited by admin on Fri Dec 15 16:12:07 GMT 2023
|
PRIMARY | |||
|
260-942-5
Created by
admin on Fri Dec 15 16:12:07 GMT 2023 , Edited by admin on Fri Dec 15 16:12:07 GMT 2023
|
PRIMARY | |||
|
m1144
Created by
admin on Fri Dec 15 16:12:07 GMT 2023 , Edited by admin on Fri Dec 15 16:12:07 GMT 2023
|
PRIMARY | Merck Index | ||
|
2FSU2FR80J
Created by
admin on Fri Dec 15 16:12:07 GMT 2023 , Edited by admin on Fri Dec 15 16:12:07 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD